Here, we report development of AAV-carried therapeutic gene construct consisting of cell-specific promoter driven Multi-Characteristic Opsin (MCO-II) to target inhibitory cells of ACC. MCO-II is highly sensitive to light and can be activated at low intensity, thus requiring a very low power budget. This along with red-light sensitiveness of MCO allows deep penetration with a minimally invasive implant. We developed a wireless Bluetooth Optogenetic Pain Modulator device for control of the dose of optogenetic stimulation. We demonstrated that red light stimulation of inhibitory neurons in ACC expressing MCO-II leads to significant reduction in pain response in fully awake animals.
The ability to both induce and monitor neural activity at cellular resolution is necessary to comprehend the activation paradigm in sensory processing and for the development of effective neuromodulation treatments. Our lab has produced an actuator-sensor construct via the hybridization of an optogenetic actuator (bMCOII) and bioluminescent Ca2+ sensor (GeNL) which allows continuous monitoring of neural activity with high spatiotemporal resolution. Modeling revealed that the construct is bound to the cell membrane through 14 transmembrane helices with the Ca2+ -bioluminescence indicator domain 20-40 Å inside the cytoplasm (membrane localization confirmed by imaging). The construct can be used to stimulate neural activity with very low intensity (10 μW/mm2 ) light but unlike fluorescent methods, requires no excitation light. Activation of the opsin causes influx of Ca2+ by opening MCOII-channels via trans-cis isomerization of all-trans-retinal. When these ions bind the indicator domain there is an increase in bioluminescence intensity. We observed significant correlation between the magnitude and kinetics of induced electrical activities and Ca2+ -bioluminescence. Longterm (>14 hours) recording of evoked neural activity in the visual cortices of murine models allowed the quantification of the strength of sensory activation. Additionally, through Artificial Intelligence-based Neural Activation Parameters, the Ca2+ -bioluminescence signals were used to map network activity patterns. We also observed delayed, secondary Ca2+ - bioluminescence responses murine visual cortices. These may be astrocyte-mediated responses to direct optogenetic and indirect visual stimulation. Our technique will enable the development of a scalable, and modular interface system which can be expanded to monitor and modulate a variety of neurological activities.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.